【市場調査レポート】ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Fanconi Anemia Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ファンコニ貧血治療のグローバル市場インサイト・予測（～2028年） / Global Fanconi Anemia Treatment Market Insights, Forecast to 2028 / QY2207C3459資料のイメージです。

• レポートコード：QY2207C3459
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、125ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のファンコニ貧血治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にファンコニ貧血治療の世界市場のxxx％を占める「血液骨髄移植」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のファンコニ貧血治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのファンコニ貧血治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのファンコニ貧血治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ファンコニ貧血治療のグローバル主要メーカーには、Allergan、Merck、Pfizer、GlaxoSmithKline、Melinta Therapeutics、Basilea Pharmaceutica、Tetraphase Pharmaceuticals、Paratek Pharmaceuticals、Nabriva Therapeutics、Spero Therapeutics、Abbott、F. Hoffmann-La Roche、Mylan N.V.、Teva Pharmaceutical Industries、Sanofi、Novartis、Bayer、Sun Pharmaceutical Industries、Aurobindo Pharma、Lupin、SHIONOGI、AbbVie、Eli Lillyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ファンコニ貧血治療市場は、種類と用途によって区分されます。世界のファンコニ貧血治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
血液骨髄移植、輸血、医薬品、その他

【用途別セグメント】
クリニック、病院、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ファンコニ貧血治療製品概要
- 種類別市場（血液骨髄移植、輸血、医薬品、その他）
- 用途別市場（クリニック、病院、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のファンコニ貧血治療販売量予測2017-2028
- 世界のファンコニ貧血治療売上予測2017-2028
- ファンコニ貧血治療の地域別販売量
- ファンコニ貧血治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ファンコニ貧血治療販売量
- 主要メーカー別ファンコニ貧血治療売上
- 主要メーカー別ファンコニ貧血治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（血液骨髄移植、輸血、医薬品、その他）
- ファンコニ貧血治療の種類別販売量
- ファンコニ貧血治療の種類別売上
- ファンコニ貧血治療の種類別価格
・用途別市場規模（クリニック、病院、その他）
- ファンコニ貧血治療の用途別販売量
- ファンコニ貧血治療の用途別売上
- ファンコニ貧血治療の用途別価格
・北米市場
- 北米のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのファンコニ貧血治療市場規模（種類別、用途別）
- 主要国別のファンコニ貧血治療市場規模（トルコ、サウジアラビア）
・企業情報
Allergan、Merck、Pfizer、GlaxoSmithKline、Melinta Therapeutics、Basilea Pharmaceutica、Tetraphase Pharmaceuticals、Paratek Pharmaceuticals、Nabriva Therapeutics、Spero Therapeutics、Abbott、F. Hoffmann-La Roche、Mylan N.V.、Teva Pharmaceutical Industries、Sanofi、Novartis、Bayer、Sun Pharmaceutical Industries、Aurobindo Pharma、Lupin、SHIONOGI、AbbVie、Eli Lilly
・産業チェーン及び販売チャネル分析
- ファンコニ貧血治療の産業チェーン分析
- ファンコニ貧血治療の原材料
- ファンコニ貧血治療の生産プロセス
- ファンコニ貧血治療の販売及びマーケティング
- ファンコニ貧血治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ファンコニ貧血治療の産業動向
- ファンコニ貧血治療のマーケットドライバー
- ファンコニ貧血治療の課題
- ファンコニ貧血治療の阻害要因
・主な調査結果

Fanconi anemia is an autosomal recessive illness marked by impaired haemopoiesis, congenital anomalies, and a significant incidence of solid tumors and acute myeloid leukaemia in patients. It is a rare disease that affects the bone marrow and is handed down via families (inherited). Fanconi anemia is indicated by shortness of breath, frequent nasal bleeding, weariness, recurring viral infection and cold, low stature and poor growth are all indications of fanconi anemia.
Market Analysis and Insights: Global Fanconi Anemia Treatment Market
The global Fanconi Anemia Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Blood and Bone Marrow Transplant accounting for % of the Fanconi Anemia Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinic segment is altered to an % CAGR throughout this forecast period.
China Fanconi Anemia Treatment market size is valued at US$ million in 2021, while the North America and Europe Fanconi Anemia Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fanconi Anemia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fanconi Anemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fanconi Anemia Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fanconi Anemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fanconi Anemia Treatment market.
Global Fanconi Anemia Treatment Scope and Market Size
Fanconi Anemia Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fanconi Anemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Blood and Bone Marrow Transplant
Blood Transfusion
Medication
Others
Segment by Application
Clinic
Hospital
Others
By Company
Allergan
Merck
Pfizer
GlaxoSmithKline
Melinta Therapeutics
Basilea Pharmaceutica
Tetraphase Pharmaceuticals
Paratek Pharmaceuticals
Nabriva Therapeutics
Spero Therapeutics
Abbott
F. Hoffmann-La Roche
Mylan N.V.
Teva Pharmaceutical Industries
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin
SHIONOGI
AbbVie
Eli Lilly
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fanconi Anemia Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood and Bone Marrow Transplant
1.2.3 Blood Transfusion
1.2.4 Medication
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fanconi Anemia Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fanconi Anemia Treatment Market Perspective (2017-2028)
2.2 Fanconi Anemia Treatment Growth Trends by Region
2.2.1 Fanconi Anemia Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fanconi Anemia Treatment Historic Market Size by Region (2017-2022)
2.2.3 Fanconi Anemia Treatment Forecasted Market Size by Region (2023-2028)
2.3 Fanconi Anemia Treatment Market Dynamics
2.3.1 Fanconi Anemia Treatment Industry Trends
2.3.2 Fanconi Anemia Treatment Market Drivers
2.3.3 Fanconi Anemia Treatment Market Challenges
2.3.4 Fanconi Anemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fanconi Anemia Treatment Players by Revenue
3.1.1 Global Top Fanconi Anemia Treatment Players by Revenue (2017-2022)
3.1.2 Global Fanconi Anemia Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Fanconi Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fanconi Anemia Treatment Revenue
3.4 Global Fanconi Anemia Treatment Market Concentration Ratio
3.4.1 Global Fanconi Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fanconi Anemia Treatment Revenue in 2021
3.5 Fanconi Anemia Treatment Key Players Head office and Area Served
3.6 Key Players Fanconi Anemia Treatment Product Solution and Service
3.7 Date of Enter into Fanconi Anemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fanconi Anemia Treatment Breakdown Data by Type
4.1 Global Fanconi Anemia Treatment Historic Market Size by Type (2017-2022)
4.2 Global Fanconi Anemia Treatment Forecasted Market Size by Type (2023-2028)
5 Fanconi Anemia Treatment Breakdown Data by Application
5.1 Global Fanconi Anemia Treatment Historic Market Size by Application (2017-2022)
5.2 Global Fanconi Anemia Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fanconi Anemia Treatment Market Size (2017-2028)
6.2 North America Fanconi Anemia Treatment Market Size by Type
6.2.1 North America Fanconi Anemia Treatment Market Size by Type (2017-2022)
6.2.2 North America Fanconi Anemia Treatment Market Size by Type (2023-2028)
6.2.3 North America Fanconi Anemia Treatment Market Share by Type (2017-2028)
6.3 North America Fanconi Anemia Treatment Market Size by Application
6.3.1 North America Fanconi Anemia Treatment Market Size by Application (2017-2022)
6.3.2 North America Fanconi Anemia Treatment Market Size by Application (2023-2028)
6.3.3 North America Fanconi Anemia Treatment Market Share by Application (2017-2028)
6.4 North America Fanconi Anemia Treatment Market Size by Country
6.4.1 North America Fanconi Anemia Treatment Market Size by Country (2017-2022)
6.4.2 North America Fanconi Anemia Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fanconi Anemia Treatment Market Size (2017-2028)
7.2 Europe Fanconi Anemia Treatment Market Size by Type
7.2.1 Europe Fanconi Anemia Treatment Market Size by Type (2017-2022)
7.2.2 Europe Fanconi Anemia Treatment Market Size by Type (2023-2028)
7.2.3 Europe Fanconi Anemia Treatment Market Share by Type (2017-2028)
7.3 Europe Fanconi Anemia Treatment Market Size by Application
7.3.1 Europe Fanconi Anemia Treatment Market Size by Application (2017-2022)
7.3.2 Europe Fanconi Anemia Treatment Market Size by Application (2023-2028)
7.3.3 Europe Fanconi Anemia Treatment Market Share by Application (2017-2028)
7.4 Europe Fanconi Anemia Treatment Market Size by Country
7.4.1 Europe Fanconi Anemia Treatment Market Size by Country (2017-2022)
7.4.2 Europe Fanconi Anemia Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fanconi Anemia Treatment Market Size (2017-2028)
8.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Type
8.2.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fanconi Anemia Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Fanconi Anemia Treatment Market Size by Application
8.3.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fanconi Anemia Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Fanconi Anemia Treatment Market Size by Region
8.4.1 Asia-Pacific Fanconi Anemia Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fanconi Anemia Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fanconi Anemia Treatment Market Size (2017-2028)
9.2 Latin America Fanconi Anemia Treatment Market Size by Type
9.2.1 Latin America Fanconi Anemia Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Fanconi Anemia Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Fanconi Anemia Treatment Market Share by Type (2017-2028)
9.3 Latin America Fanconi Anemia Treatment Market Size by Application
9.3.1 Latin America Fanconi Anemia Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Fanconi Anemia Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Fanconi Anemia Treatment Market Share by Application (2017-2028)
9.4 Latin America Fanconi Anemia Treatment Market Size by Country
9.4.1 Latin America Fanconi Anemia Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Fanconi Anemia Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fanconi Anemia Treatment Market Size (2017-2028)
10.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Type
10.2.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fanconi Anemia Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Fanconi Anemia Treatment Market Size by Application
10.3.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fanconi Anemia Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Fanconi Anemia Treatment Market Size by Country
10.4.1 Middle East & Africa Fanconi Anemia Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fanconi Anemia Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Fanconi Anemia Treatment Introduction
11.1.4 Allergan Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.1.5 Allergan Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Fanconi Anemia Treatment Introduction
11.2.4 Merck Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Fanconi Anemia Treatment Introduction
11.3.4 Pfizer Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Fanconi Anemia Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Company Details
11.5.2 Melinta Therapeutics Business Overview
11.5.3 Melinta Therapeutics Fanconi Anemia Treatment Introduction
11.5.4 Melinta Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.5.5 Melinta Therapeutics Recent Developments
11.6 Basilea Pharmaceutica
11.6.1 Basilea Pharmaceutica Company Details
11.6.2 Basilea Pharmaceutica Business Overview
11.6.3 Basilea Pharmaceutica Fanconi Anemia Treatment Introduction
11.6.4 Basilea Pharmaceutica Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.6.5 Basilea Pharmaceutica Recent Developments
11.7 Tetraphase Pharmaceuticals
11.7.1 Tetraphase Pharmaceuticals Company Details
11.7.2 Tetraphase Pharmaceuticals Business Overview
11.7.3 Tetraphase Pharmaceuticals Fanconi Anemia Treatment Introduction
11.7.4 Tetraphase Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.7.5 Tetraphase Pharmaceuticals Recent Developments
11.8 Paratek Pharmaceuticals
11.8.1 Paratek Pharmaceuticals Company Details
11.8.2 Paratek Pharmaceuticals Business Overview
11.8.3 Paratek Pharmaceuticals Fanconi Anemia Treatment Introduction
11.8.4 Paratek Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.8.5 Paratek Pharmaceuticals Recent Developments
11.9 Nabriva Therapeutics
11.9.1 Nabriva Therapeutics Company Details
11.9.2 Nabriva Therapeutics Business Overview
11.9.3 Nabriva Therapeutics Fanconi Anemia Treatment Introduction
11.9.4 Nabriva Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.9.5 Nabriva Therapeutics Recent Developments
11.10 Spero Therapeutics
11.10.1 Spero Therapeutics Company Details
11.10.2 Spero Therapeutics Business Overview
11.10.3 Spero Therapeutics Fanconi Anemia Treatment Introduction
11.10.4 Spero Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.10.5 Spero Therapeutics Recent Developments
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Fanconi Anemia Treatment Introduction
11.11.4 Abbott Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.11.5 Abbott Recent Developments
11.12 F. Hoffmann-La Roche
11.12.1 F. Hoffmann-La Roche Company Details
11.12.2 F. Hoffmann-La Roche Business Overview
11.12.3 F. Hoffmann-La Roche Fanconi Anemia Treatment Introduction
11.12.4 F. Hoffmann-La Roche Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.12.5 F. Hoffmann-La Roche Recent Developments
11.13 Mylan N.V.
11.13.1 Mylan N.V. Company Details
11.13.2 Mylan N.V. Business Overview
11.13.3 Mylan N.V. Fanconi Anemia Treatment Introduction
11.13.4 Mylan N.V. Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.13.5 Mylan N.V. Recent Developments
11.14 Teva Pharmaceutical Industries
11.14.1 Teva Pharmaceutical Industries Company Details
11.14.2 Teva Pharmaceutical Industries Business Overview
11.14.3 Teva Pharmaceutical Industries Fanconi Anemia Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.14.5 Teva Pharmaceutical Industries Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Fanconi Anemia Treatment Introduction
11.15.4 Sanofi Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.15.5 Sanofi Recent Developments
11.16 Novartis
11.16.1 Novartis Company Details
11.16.2 Novartis Business Overview
11.16.3 Novartis Fanconi Anemia Treatment Introduction
11.16.4 Novartis Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.16.5 Novartis Recent Developments
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Fanconi Anemia Treatment Introduction
11.17.4 Bayer Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.17.5 Bayer Recent Developments
11.18 Sun Pharmaceutical Industries
11.18.1 Sun Pharmaceutical Industries Company Details
11.18.2 Sun Pharmaceutical Industries Business Overview
11.18.3 Sun Pharmaceutical Industries Fanconi Anemia Treatment Introduction
11.18.4 Sun Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.18.5 Sun Pharmaceutical Industries Recent Developments
11.19 Aurobindo Pharma
11.19.1 Aurobindo Pharma Company Details
11.19.2 Aurobindo Pharma Business Overview
11.19.3 Aurobindo Pharma Fanconi Anemia Treatment Introduction
11.19.4 Aurobindo Pharma Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.19.5 Aurobindo Pharma Recent Developments
11.20 Lupin
11.20.1 Lupin Company Details
11.20.2 Lupin Business Overview
11.20.3 Lupin Fanconi Anemia Treatment Introduction
11.20.4 Lupin Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.20.5 Lupin Recent Developments
11.21 SHIONOGI
11.21.1 SHIONOGI Company Details
11.21.2 SHIONOGI Business Overview
11.21.3 SHIONOGI Fanconi Anemia Treatment Introduction
11.21.4 SHIONOGI Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.21.5 SHIONOGI Recent Developments
11.22 AbbVie
11.22.1 AbbVie Company Details
11.22.2 AbbVie Business Overview
11.22.3 AbbVie Fanconi Anemia Treatment Introduction
11.22.4 AbbVie Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.22.5 AbbVie Recent Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Details
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly Fanconi Anemia Treatment Introduction
11.23.4 Eli Lilly Revenue in Fanconi Anemia Treatment Business (2017-2022)
11.23.5 Eli Lilly Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Fanconi Anemia Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Blood and Bone Marrow Transplant
Table 3. Key Players of Blood Transfusion
Table 4. Key Players of Medication
Table 5. Key Players of Others
Table 6. Global Fanconi Anemia Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Fanconi Anemia Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Fanconi Anemia Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Fanconi Anemia Treatment Market Share by Region (2017-2022)
Table 10. Global Fanconi Anemia Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Fanconi Anemia Treatment Market Share by Region (2023-2028)
Table 12. Fanconi Anemia Treatment Market Trends
Table 13. Fanconi Anemia Treatment Market Drivers
Table 14. Fanconi Anemia Treatment Market Challenges
Table 15. Fanconi Anemia Treatment Market Restraints
Table 16. Global Fanconi Anemia Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Fanconi Anemia Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Fanconi Anemia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fanconi Anemia Treatment as of 2021)
Table 19. Ranking of Global Top Fanconi Anemia Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Fanconi Anemia Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fanconi Anemia Treatment Product Solution and Service
Table 23. Date of Enter into Fanconi Anemia Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Fanconi Anemia Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Fanconi Anemia Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Fanconi Anemia Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Fanconi Anemia Treatment Revenue Share by Application (2017-2022)
Table 31. Global Fanconi Anemia Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Fanconi Anemia Treatment Revenue Share by Application (2023-2028)
Table 33. North America Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Fanconi Anemia Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Fanconi Anemia Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Fanconi Anemia Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Fanconi Anemia Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Fanconi Anemia Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Fanconi Anemia Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Fanconi Anemia Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Fanconi Anemia Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Fanconi Anemia Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Fanconi Anemia Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Fanconi Anemia Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Fanconi Anemia Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Fanconi Anemia Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Fanconi Anemia Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Fanconi Anemia Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Fanconi Anemia Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Fanconi Anemia Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Fanconi Anemia Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Fanconi Anemia Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Fanconi Anemia Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Fanconi Anemia Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Fanconi Anemia Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Fanconi Anemia Treatment Product
Table 66. Allergan Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 67. Allergan Recent Developments
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Fanconi Anemia Treatment Product
Table 71. Merck Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Fanconi Anemia Treatment Product
Table 76. Pfizer Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 77. Pfizer Recent Developments
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Fanconi Anemia Treatment Product
Table 81. GlaxoSmithKline Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 82. GlaxoSmithKline Recent Developments
Table 83. Melinta Therapeutics Company Details
Table 84. Melinta Therapeutics Business Overview
Table 85. Melinta Therapeutics Fanconi Anemia Treatment Product
Table 86. Melinta Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 87. Melinta Therapeutics Recent Developments
Table 88. Basilea Pharmaceutica Company Details
Table 89. Basilea Pharmaceutica Business Overview
Table 90. Basilea Pharmaceutica Fanconi Anemia Treatment Product
Table 91. Basilea Pharmaceutica Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 92. Basilea Pharmaceutica Recent Developments
Table 93. Tetraphase Pharmaceuticals Company Details
Table 94. Tetraphase Pharmaceuticals Business Overview
Table 95. Tetraphase Pharmaceuticals Fanconi Anemia Treatment Product
Table 96. Tetraphase Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 97. Tetraphase Pharmaceuticals Recent Developments
Table 98. Paratek Pharmaceuticals Company Details
Table 99. Paratek Pharmaceuticals Business Overview
Table 100. Paratek Pharmaceuticals Fanconi Anemia Treatment Product
Table 101. Paratek Pharmaceuticals Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 102. Paratek Pharmaceuticals Recent Developments
Table 103. Nabriva Therapeutics Company Details
Table 104. Nabriva Therapeutics Business Overview
Table 105. Nabriva Therapeutics Fanconi Anemia Treatment Product
Table 106. Nabriva Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 107. Nabriva Therapeutics Recent Developments
Table 108. Spero Therapeutics Company Details
Table 109. Spero Therapeutics Business Overview
Table 110. Spero Therapeutics Fanconi Anemia Treatment Product
Table 111. Spero Therapeutics Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 112. Spero Therapeutics Recent Developments
Table 113. Abbott Company Details
Table 114. Abbott Business Overview
Table 115. Abbott Fanconi Anemia Treatment Product
Table 116. Abbott Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 117. Abbott Recent Developments
Table 118. F. Hoffmann-La Roche Company Details
Table 119. F. Hoffmann-La Roche Business Overview
Table 120. F. Hoffmann-La Roche Fanconi Anemia Treatment Product
Table 121. F. Hoffmann-La Roche Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 122. F. Hoffmann-La Roche Recent Developments
Table 123. Mylan N.V. Company Details
Table 124. Mylan N.V. Business Overview
Table 125. Mylan N.V. Fanconi Anemia Treatment Product
Table 126. Mylan N.V. Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 127. Mylan N.V. Recent Developments
Table 128. Teva Pharmaceutical Industries Company Details
Table 129. Teva Pharmaceutical Industries Business Overview
Table 130. Teva Pharmaceutical Industries Fanconi Anemia Treatment Product
Table 131. Teva Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 132. Teva Pharmaceutical Industries Recent Developments
Table 133. Sanofi Company Details
Table 134. Sanofi Business Overview
Table 135. Sanofi Fanconi Anemia Treatment Product
Table 136. Sanofi Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 137. Sanofi Recent Developments
Table 138. Novartis Company Details
Table 139. Novartis Business Overview
Table 140. Novartis Fanconi Anemia Treatment Product
Table 141. Novartis Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 142. Novartis Recent Developments
Table 143. Bayer Company Details
Table 144. Bayer Business Overview
Table 145. Bayer Fanconi Anemia Treatment Product
Table 146. Bayer Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 147. Bayer Recent Developments
Table 148. Sun Pharmaceutical Industries Company Details
Table 149. Sun Pharmaceutical Industries Business Overview
Table 150. Sun Pharmaceutical Industries Fanconi Anemia Treatment Product
Table 151. Sun Pharmaceutical Industries Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 152. Sun Pharmaceutical Industries Recent Developments
Table 153. Aurobindo Pharma Company Details
Table 154. Aurobindo Pharma Business Overview
Table 155. Aurobindo Pharma Fanconi Anemia Treatment Product
Table 156. Aurobindo Pharma Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 157. Aurobindo Pharma Recent Developments
Table 158. Lupin Company Details
Table 159. Lupin Business Overview
Table 160. Lupin Fanconi Anemia Treatment Product
Table 161. Lupin Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 162. Lupin Recent Developments
Table 163. SHIONOGI Company Details
Table 164. SHIONOGI Business Overview
Table 165. SHIONOGI Fanconi Anemia Treatment Product
Table 166. SHIONOGI Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 167. SHIONOGI Recent Developments
Table 168. AbbVie Company Details
Table 169. AbbVie Business Overview
Table 170. AbbVie Fanconi Anemia Treatment Product
Table 171. AbbVie Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 172. AbbVie Recent Developments
Table 173. Eli Lilly Company Details
Table 174. Eli Lilly Business Overview
Table 175. Eli Lilly Fanconi Anemia Treatment Product
Table 176. Eli Lilly Revenue in Fanconi Anemia Treatment Business (2017-2022) & (US$ Million)
Table 177. Eli Lilly Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fanconi Anemia Treatment Market Share by Type: 2021 VS 2028
Figure 2. Blood and Bone Marrow Transplant Features
Figure 3. Blood Transfusion Features
Figure 4. Medication Features
Figure 5. Others Features
Figure 6. Global Fanconi Anemia Treatment Market Share by Application: 2021 VS 2028
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Fanconi Anemia Treatment Report Years Considered
Figure 11. Global Fanconi Anemia Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Fanconi Anemia Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Fanconi Anemia Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Fanconi Anemia Treatment Market Share by Players in 2021
Figure 15. Global Top Fanconi Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fanconi Anemia Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Fanconi Anemia Treatment Revenue in 2021
Figure 17. North America Fanconi Anemia Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Fanconi Anemia Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Fanconi Anemia Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Fanconi Anemia Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Fanconi Anemia Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Fanconi Anemia Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Fanconi Anemia Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Fanconi Anemia Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Fanconi Anemia Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Fanconi Anemia Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Fanconi Anemia Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Fanconi Anemia Treatment Market Size Share by Region (2017-2028)
Figure 37. China Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Fanconi Anemia Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Fanconi Anemia Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Fanconi Anemia Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Fanconi Anemia Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Fanconi Anemia Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Fanconi Anemia Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Fanconi Anemia Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Fanconi Anemia Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Fanconi Anemia Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Allergan Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 60. Melinta Therapeutics Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 61. Basilea Pharmaceutica Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 62. Tetraphase Pharmaceuticals Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 63. Paratek Pharmaceuticals Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 64. Nabriva Therapeutics Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 65. Spero Therapeutics Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 66. Abbott Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 68. Mylan N.V. Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 69. Teva Pharmaceutical Industries Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 70. Sanofi Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 71. Novartis Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 72. Bayer Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 73. Sun Pharmaceutical Industries Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 74. Aurobindo Pharma Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 75. Lupin Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 76. SHIONOGI Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 77. AbbVie Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 78. Eli Lilly Revenue Growth Rate in Fanconi Anemia Treatment Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

以下、関連資料のご紹介

結膜炎治療のグローバル市場インサイト・予測（～2028年）

Global Conjunctivitis Treatment Market Insights, Forecast to 2028
QY2207C3480 2022年7月11日 78Pages
新型コロナウイルス感染症のパンデミックにより、世界の結膜炎治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に結膜炎治療の世界市場のxx...

脳がん治療のグローバル市場インサイト・予測（～2028年）

Global Brain Cancer Treatment Market Insights, Forecast to 2028
QY2207C3466 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の脳がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳がん治療の世界市場のxx...

眼がん治療のグローバル市場インサイト・予測（～2028年）

Global Eye Cancer Treatment Market Insights, Forecast to 2028
QY2207C3457 2022年7月11日 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の眼がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼がん治療の世界市場のxx...

地図状萎縮治療のグローバル市場インサイト・予測（～2028年）

Global Geographic Atrophy Treatment Market Insights, Forecast to 2028
QY2207C3463 2022年7月11日 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の地図状萎縮治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に地図状萎縮治療の世界市...

糖尿病性眼疾患治療のグローバル市場インサイト・予測（～2028年）

Global Diabetes Associated Ophthalmic Treatment Market Insights, Forecast to 2028
QY2207C3487 2022年7月11日 115Pages
新型コロナウイルス感染症のパンデミックにより、世界の糖尿病性眼疾患治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糖尿病性眼疾患治療...

フィールド輸血キット（FBTK）のグローバル市場インサイト・予測（～2028年） The Field Blood Transfusion Kit is a standalone skill set module to collect and transfuse fresh whole blood. Market Analysis and Insights: Global Field Blood Transfusion Kit (FBTK) Market Due to the COVID-19 pandemic, the global Field Blood Transfusion Kit (FBTK) market size is estimated to be worth…
結膜炎治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Conjunctivitis Treatment Market The global Conjunctivitis Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Antibiotic accountin…
眼がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Eye Cancer Treatment Market The global Eye Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the…
地図状萎縮治療のグローバル市場インサイト・予測（～2028年） Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically star…
脳がん治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Brain Cancer Treatment Market The global Brain Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Chemotherapy accounting …